loading

Black Diamond Therapeutics Inc Aktie (BDTX) Neueste Nachrichten

pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Boosts Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

BDTX stock touches 52-week low at $2.31 amid market challenges - Investing.com India

Dec 19, 2024
pulisher
Dec 18, 2024

Analytical Overview: Black Diamond Therapeutics Inc (BDTX)’s Ratios Tell a Financial Story - The Dwinnex

Dec 18, 2024
pulisher
Dec 18, 2024

Fmr LLC Makes New Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Dec 18, 2024
pulisher
Dec 12, 2024

US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks - Simply Wall St

Dec 12, 2024
pulisher
Dec 11, 2024

Black Diamond (BDTX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Dec 11, 2024
pulisher
Dec 11, 2024

Fmr LLC Decreases Stock Position in Mobileye Global Inc. (NASDAQ:MBLY) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

MFA Financial, Inc. (NYSE:MFA) Shares Sold by Fmr LLC - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

BNP Paribas Financial Markets Purchases 111,027 Shares of Under Armour, Inc. (NYSE:UA) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

Fmr LLC Has $15.49 Million Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

MetLife Investment Management LLC Raises Stake in Smith-Midland Co. (NASDAQ:SMID) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

BNP Paribas Financial Markets Raises Stake in RadNet, Inc. (NASDAQ:RDNT) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

Fmr LLC Increases Position in AppFolio, Inc. (NASDAQ:APPF) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

Fmr LLC Raises Stock Position in ADT Inc. (NYSE:ADT) - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

Charles Schwab Investment Management Inc. Sells 309,336 Shares of Unisys Co. (NYSE:UIS) - Defense World

Dec 11, 2024
pulisher
Dec 10, 2024

Point72 Asset Management L.P. Takes $3.03 Million Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - MarketBeat

Dec 10, 2024
pulisher
Nov 29, 2024

Vestal Point Capital LP Purchases 2,928,500 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Gene and Cell Therapies Targeting CNS Disorders Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight - The Globe and Mail

Nov 29, 2024
pulisher
Nov 29, 2024

Gene and Cell Therapies Targeting CNS Disorders Treatment - openPR

Nov 29, 2024
pulisher
Nov 27, 2024

Genesis Therapeutics presents new PI3Kα mutant inhibitors - BioWorld Online

Nov 27, 2024
pulisher
Nov 16, 2024

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Decrease in Short Interest - MarketBeat

Nov 16, 2024
pulisher
Nov 14, 2024

T. Rowe Price Investment Management, Inc. Expands Stake in Black Diamond Therapeutics Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Vestal Point Capital, LP Increases Stake in Black Diamond Therap - GuruFocus.com

Nov 14, 2024
pulisher
Nov 08, 2024

What is HC Wainwright's Estimate for BDTX FY2024 Earnings? - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Wedbush Has Optimistic View of BDTX FY2024 Earnings - MarketBeat

Nov 08, 2024
pulisher
Nov 06, 2024

Black Diamond Therapeutics (NASDAQ:BDTX) Receives "Buy" Rating from HC Wainwright - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 06, 2024
pulisher
Nov 05, 2024

Black Diamond Therapeutics Reports Promising Q3 2024 Results - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

Black Diamond: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 05, 2024
pulisher
Nov 05, 2024

BDTXBlack Diamond Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks - Simply Wall St

Nov 05, 2024
pulisher
Nov 05, 2024

Black Diamond's BDTX-1535 Shows 42% Response Rate in Lung Cancer Trial, Reports Q3 Results | BDTX Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 02, 2024

Black Diamond Group Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 02, 2024
pulisher
Nov 01, 2024

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Nov 01, 2024
pulisher
Nov 01, 2024

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Growth in Short Interest - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 5.9% in October - MarketBeat

Oct 31, 2024
pulisher
Oct 26, 2024

Foundations Investment Advisors LLC Has $445,000 Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Oct 26, 2024
pulisher
Oct 16, 2024

Black Diamond Therapeutics Inc (BDTX) looking to reclaim success with recent performance - SETE News

Oct 16, 2024
pulisher
Oct 15, 2024

Investing in Black Diamond Therapeutics Inc (BDTX) Is Getting More Attractive - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Results from Black Diamond Therapeutics Inc (BDTX) show potential - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Market Update: Black Diamond Therapeutics Inc (BDTX) Sees Negative Movement, Closing at 3.33 - The Dwinnex

Oct 14, 2024
pulisher
Oct 13, 2024

Dimensional Fund Advisors LP Has $932,000 Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Oct 13, 2024
pulisher
Oct 11, 2024

Black Diamond Therapeutics Inc (BDTX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle

Oct 11, 2024
pulisher
Oct 11, 2024

Black Diamond Therapeutics Inc [BDTX] Records 200-Day SMA of $4.87 - Knox Daily

Oct 11, 2024
pulisher
Oct 11, 2024

FY2024 EPS Estimates for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Increased by Analyst - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Analysts’ Recent Ratings Changes for Black Diamond Therapeutics (BDTX) - Defense World

Oct 10, 2024
pulisher
Oct 10, 2024

Black Diamond Therapeutics Inc (BDTX) is looking forward to a strong quarter - SETE News

Oct 10, 2024
pulisher
Oct 10, 2024

Cuts for Black Diamond as runway's end nears - The Pharma Letter

Oct 10, 2024
pulisher
Oct 10, 2024

Q3 2024 Earnings Estimate for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Issued By Wedbush - MarketBeat

Oct 10, 2024
pulisher
Oct 10, 2024

Layoffs at local cancer drug developer; Flagship names new managing partner - The Business Journals

Oct 10, 2024
pulisher
Oct 09, 2024

Black Diamond Therapeutics (NASDAQ:BDTX) Earns "Buy" Rating from HC Wainwright - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Black Diamond: EGFRm NSCLC Targeting Continues With Q1 Of 2025 Data (BDTX) - Seeking Alpha

Oct 08, 2024
pulisher
Oct 08, 2024

Black Diamond refocuses on lead cancer drug, extends cash runway - Investing.com India

Oct 08, 2024
pulisher
Oct 08, 2024

Black Diamond Therapeutics (NASDAQ:BDTX) Given Outperform Rating at Wedbush - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Piper Sandler maintains Overweight rating on Black Diamond Therapeutics shares - Investing.com Canada

Oct 08, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):